OTC · AVHNY
Industrials · Engineering & Construction
$26.30
Up+$0.00 (+0.00%)
Updated Sep 12, 2026, 12:15 AM
SID Score
5.7/10
Composite research score
Smart Money
46/100
Neutral
Price performance
1M range · 0 trading sessions · Daily adjusted prices
AVHNY does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning AVHNY.
AVHNY research
Company profile and research snapshot.
ACKERMANS & VN HRN UN/ADR
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jun 11, 2026 | ING FM | Hold | — |
| Jun 7, 2026 | BAADER EUROPE / ALPHAVALUE | Buy | — |
| Jun 2, 2026 | BERENBERG | Buy | — |
| May 20, 2026 | DEGROOF PETERCAM | Hold | — |
| May 20, 2026 | ODDO BHF | Buy | — |
No generated briefing is available yet.
GlobeNewswire Inc. · Dec 11, 2025
DISCO Pharmaceuticals appointed Mark Manfredi as CEO and closed a €36 million seed financing round to advance its surfaceome-targeted drug candidates for cancer treatment, with support from multiple venture capital investors.
GlobeNewswire Inc. · Sep 2, 2025
Ackermans & van Haaren has committed $20 million to the second investment fund managed by Venturi Partners, signaling continued strategic investment in venture capital.
GlobeNewswire Inc. · Sep 2, 2025
Ackermans & van Haaren has invested 20 million US dollars in the second fund of Venturi Partners, demonstrating continued strategic investment in financial partnerships.
GlobeNewswire Inc. · Sep 2, 2025
Ackermans & van Haaren has committed $20 million to the second fund of Venturi Partners, demonstrating continued investment in strategic partnerships and growth opportunities.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning AVHNY.
No results
No recent SID articles mention AVHNY.
